Getting More From Right Heart Catheterization: A Focus on the Right Ventricle

[1]  D. Kass,et al.  Compartmentalization of Cardiac &bgr;-Adrenergic Inotropy Modulation by Phosphodiesterase Type 5 , 2007 .

[2]  Z. Jing,et al.  Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. , 2006, Journal of the American College of Cardiology.

[3]  O. Vignaux,et al.  Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and Tissue-Doppler echography study. , 2006, The Journal of rheumatology.

[4]  R. Naeije,et al.  Endothelin receptor antagonists. , 2006, Pharmacology & therapeutics.

[5]  Paul Sorajja,et al.  Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. , 2006, Journal of the American College of Cardiology.

[6]  Michael F O'Rourke,et al.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.

[7]  D. DeMets,et al.  Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. , 2005, Journal of cardiac failure.

[8]  D. Kass,et al.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.

[9]  M. Zaccolo,et al.  cGMP Catabolism by Phosphodiesterase 5A Regulates Cardiac Adrenergic Stimulation by NOS3-Dependent Mechanism , 2004, Circulation research.

[10]  A. Torbicki,et al.  Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[11]  R. Naeije,et al.  Feasibility of routine pulmonary arterial impedance measurements in pulmonary hypertension. , 2004, Chest.

[12]  D. Kass,et al.  Assessment of left ventricular end-systolic elastance from aortic pressure-left ventricular volume relations , 2002, Heart and Vessels.

[13]  Y Lecarpentier,et al.  Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension. , 2001, Journal of the American College of Cardiology.

[14]  R. Naeije,et al.  Continuous versus pulsatile pulmonary hemodynamics in canine oleic acid lung injury. , 2000, American journal of respiratory and critical care medicine.

[15]  D. Kass,et al.  Hemodynamic effects of unloading the old heart. , 1999, American journal of physiology. Heart and circulatory physiology.

[16]  C H Chen,et al.  Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. , 1998, Journal of the American College of Cardiology.

[17]  L. Rubin,et al.  Primary pulmonary hypertension , 1998, The Lancet.

[18]  P. Kolh,et al.  Time domain method to identify simultaneously parameters of the windkessel model applied to the pulmonary circulation. , 1998, Archives of physiology and biochemistry.

[19]  D. Kass,et al.  Assessment of ventricular function in dilated cardiomyopathies. , 1995, Current opinion in cardiology.

[20]  B. Wilcox,et al.  Effects of chronically elevated pulmonary arterial pressure and flow on right ventricular afterload. , 1994, The American journal of physiology.

[21]  B. Lieber,et al.  Beat-by-beat changes of viscoelastic and inertial properties of the pulmonary arteries. , 1994, Journal of applied physiology.

[22]  P. Fourie,et al.  Effect of compliance on a time-domain estimate of the characteristic impedance of the pulmonary artery during acute pulmonary hypertension , 1993, Medical and Biological Engineering and Computing.

[23]  D. Kass,et al.  Pressure-volume analysis of changes in cardiac function in chronic cardiomyoplasty. , 1993, The Annals of thoracic surgery.

[24]  R. Naeije,et al.  Pulmonary vascular impedance vs. resistance in hypoxic and hyperoxic dogs: effects of propofol and isoflurane. , 1993, Journal of applied physiology.

[25]  D. Kass.  Clinical evaluation of left heart function by conductance catheter technique. , 1992, European heart journal.

[26]  David A. Kass,et al.  Effective Arterial Elastance as Index of Arterial Vascular Load in Humans , 1992, Circulation.

[27]  K. Stenmark,et al.  Pulmonary vascular impedance and wave reflections in the hypoxic calf. , 1992, Journal of applied physiology.

[28]  D. Kass,et al.  Reduced Left Ventricular Compliance in Human Mitral Stenosis: Role of Reversible Internal Constraint , 1992, Circulation.

[29]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[30]  H. Piene.  Pulmonary arterial impedance and right ventricular function. , 1986, Physiological reviews.

[31]  M. Oberholzer,et al.  Influence of age on pulmonary haemodynamics at rest and during supine exercise. , 1983, Clinical science.

[32]  M F O'Rourke,et al.  Vascular impedance in studies of arterial and cardiac function. , 1982, Physiological reviews.

[33]  A. Zaiman,et al.  PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[34]  M. O'Rourke,et al.  Physiological and pathophysiological implications of ventricular/vascular coupling , 2006, Annals of Biomedical Engineering.

[35]  W. Laskey,et al.  Right ventricular-pulmonary arterial interactions , 2006, Annals of Biomedical Engineering.

[36]  David A. Kass,et al.  Age-related Changes in Venticular–Arterial Coupling: Pathophysiologic Implications , 2004, Heart Failure Reviews.

[37]  S. Permutt,et al.  Exercise and the pulmonary circulation , 1991 .

[38]  W L Maughan,et al.  Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. , 1988, Catheterization and cardiovascular diagnosis.